Odyssey Health (ODYY) Total Debt Growth (1y) (2015 - 2026)
Odyssey Health (ODYY) Total Debt Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn | 0.12% |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn | -5.76% |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 19.06% |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | -33.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -33.51% |
| Jan 31, 2026 | 96.42% |
| Oct 31, 2025 | -5.15% |
| Jul 31, 2025 | 19.73% |
| Apr 30, 2025 | 21.23% |
| Jan 31, 2025 | 27.48% |
| Oct 31, 2024 | -19.68% |
| Jul 31, 2024 | -27.30% |
| Apr 30, 2024 | -20.52% |
| Jan 31, 2024 | -24.94% |
| Oct 31, 2023 | 47.92% |
| Jul 31, 2023 | 48.80% |
| Apr 30, 2023 | 152.67% |
| Jan 31, 2023 | 179.73% |
| Oct 31, 2022 | 189.45% |
| Jul 31, 2022 | 63.80% |
| Apr 30, 2022 | 134.69% |
| Jan 31, 2022 | 249.67% |
| Oct 31, 2021 | 284.83% |
| Jul 31, 2021 | 598.05% |